Silence Therapeutics (SLN.US) Latest Stock News - Major News Analysis

Event Tracking

Nov10

H.C. Wainwright Analyst Reiterates Buy Rating on Silence Therapeutics

15:42

Nov7

Silence Therapeutics released FY2025 9 Months Earnings on November 6, 2025 (EST), with actual revenue of USD 525K and EPS of USD -1.6332

04:00

Silence Therapeutics released FY2025 Q3 earnings on November 6 (EST), actual revenue USD 159 K (forecast USD 5.748 M), actual EPS USD -0.45 (forecast USD -0.148)

04:00

Nov5

Minter rates Silence Therapeutics as a Strong Buy

12:38

Oct23

Silence Therapeutics Completes Patient Recruitment for divesiran's Second-Phase Study

11:46

Oct16

Myles Minter Gives Silence Therapeutics a Buy Rating

10:11

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 159 K, Net Income -20.96 M, EPS -0.45

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 224 K, Net Income -27.35 M, EPS -0.5791

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 142 K, Net Income -28.53 M, EPS -0.6041

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change